Recombinant tissue plasminogen activator: in my community hospital ED, will early administration of rt-PA to patients with the initial diagnosis of acute ischemic stroke reduce mortality and disability?
Wyer
P C
PC
Department of Emergency Medicine, Columbia Presbyterian Medical Center, New York City, New York, USA. aW690@idt.net
Osborn
H H
HH
D000208:Acute Disease; D002545:Brain Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D004636:Emergency Service, Hospital; D019317:Evidence-Based Medicine / Q000379:methods*; D005260:Female; D006764:Hospitals, Community; D006801:Humans; D016239:MEDLINE; D008297:Male; D010960:Plasminogen Activators / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D014481:United States
D011994:Recombinant Proteins; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator